Omega Fund Management, LLC Fibrogen Inc Transaction History

Omega Fund Management, LLC

  • $67.4 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $1.3 Million - $2.01 Million
-130,646 Closed
0 $0
Q4 2017

Feb 05, 2018
SELL
$41.95 - $60.1 $7.71 Million - $11 Million
-183,702 Reduced 58.44%
130,646 $6.19 Million
Q3 2017

Nov 03, 2017
BUY
$33.4 - $53.9 $10.5 Million - $16.9 Million
314,348
314,348 $16.9 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email